세계의 의약품 포장 시장 : 포장 유형별, 제품별, 약제 유형별, 처방 유형별, 최종 용도별, 지역별 - 시장 규모, 산업 역학, 기회 분석, 예측(2025-2033년)

Pharmaceutical packaging refers to the materials and processes utilized to enclose and safeguard medicinal products throughout their entire lifecycle. In 2024, the pharmaceutical packaging market was valued at approximately US$ 177.0 billion, reflecting its significant scale and importance within the broader healthcare industry. Projections indicate that this market will experience remarkable growth over the coming decade, with an anticipated valuation reaching US$ 612.9 billion by 2033. This forecast corresponds to a compound annual growth rate (CAGR) of 14.8% between 2025 and 2033, underscoring the rapid expansion and evolving dynamics within the sector.

The pharmaceutical packaging industry's unprecedented growth is driven by a convergence of several key factors. Foremost among these is the aging global population, which is expanding rapidly and increasing demand for a variety of medications. Older adults typically require more complex treatment regimens, often involving multiple drugs, which necessitates sophisticated packaging solutions designed to enhance safety, usability, and adherence. Additionally, the rising prevalence of chronic diseases such as diabetes, cardiovascular disorders, and cancer is fueling sustained demand for pharmaceutical products.

Noteworthy Market Developments

The pharmaceutical packaging market is characterized by a high degree of fragmentation, consisting of a diverse mix of large multinational corporations, medium-sized enterprises, and numerous small domestic players. Firms such as International Paper, WestRock Company, and CCL Industries are notable for their offerings in folding cartons and other secondary packaging materials. These products play an essential role in protecting primary packaging during storage and transportation, as well as providing important branding and regulatory information to end consumers.

Recent strategic moves within the market underscore ongoing consolidation and innovation. For example, Alvotech, a key player in the sector, announced its acquisition of Ivers-Lee Group, a Swiss company specializing in pharmaceutical assembly and packaging services. This acquisition strategically integrates Ivers-Lee's operations into Alvotech's Technical Operations division, enhancing its service capabilities while preserving Ivers-Lee as a separate legal entity.

Innovation within the market is also evident in the development of environmentally conscious packaging solutions. Cold Chain Technologies (CCT) recently launched a curbside recyclable parcel shipper portfolio designed specifically for first-mile, parcel-sized shipments. This new product ensures that temperature-sensitive pharmaceutical products remain thermally protected during transit, a critical factor for maintaining the efficacy of many drugs.

Core Growth Drivers

The aging demographic shift is profoundly reshaping the pharmaceutical packaging market, driven by the rapid growth of the global population aged 65 and older. In 2024, this segment reached approximately 761 million individuals, and projections indicate it will double by 2050. This expanding elderly population places significantly greater demands on healthcare systems, as older adults typically consume about three times more prescription medications compared to younger age groups.

Pharmaceutical companies such as Pfizer and Novartis have underscored the economic impact of this demographic trend, reporting that products specifically targeting age-related conditions generate annual revenues of roughly US$ 478 billion globally. This substantial market value reflects the growing focus on developing treatments for diseases commonly associated with aging, including cardiovascular disorders, arthritis, neurodegenerative diseases, and osteoporosis.

Emerging Opportunity Trends

Generic medications have revolutionized healthcare accessibility across emerging markets, driving an unprecedented surge in demand within the pharmaceutical packaging market. Since 2020, approximately 2.8 billion people in these regions have gained first-time access to essential medicines, largely due to the widespread availability and affordability of generic drugs. This dramatic increase in access has created significant pressure on packaging manufacturers to scale up production and innovate solutions that meet the diverse and growing needs of these expanding markets.

India stands as a global powerhouse in the generic pharmaceutical sector, producing an estimated 60,000 generic drug brands. To support this massive output, the country requires around 45 billion packaging units annually, serving both its vast domestic population and international markets. India's pharmaceutical packaging industry must therefore operate on an enormous scale, balancing high-volume production with stringent quality and regulatory standards to ensure the safe delivery of medications worldwide.

Barriers to Optimization

Personalized medicine is fundamentally transforming pharmaceutical manufacturing paradigms, imposing new challenges and opportunities on the pharmaceutical packaging market. Traditional large-scale, uniform production methods are giving way to highly specialized processes that must accommodate small production runs tailored to individual patients. In some cases, this means producing as few as 100 units per batch to meet the precise requirements of patient-specific therapies.

This shift toward personalization is particularly evident in advanced treatments such as CAR-T cell therapies, which have gained approval for around 15,000 patients annually. These therapies necessitate individualized packaging solutions that not only ensure safety and efficacy but also provide cryogenic storage capabilities to maintain the delicate biological materials involved. The cost of these specialized patient kits can reach as high as US$ 12,000 each, reflecting the complexity and precision required.

Detailed Market Segmentation

By Packaging Type, the primary packaging segment holds a commanding 72% share of the market. This dominance is reinforced by revolutionary advancements that enhance the safety, integrity, and functionality of primary packaging solutions. One of the most significant innovations is the integration of embedded temperature indicators that provide rapid visual cues when products experience temperature excursions outside the critical 2-8°C range. These indicators can change color within just 12 seconds of exposure to improper temperatures, allowing for immediate detection of potential product compromise.

By Application, oral drug packaging holds a commanding position in the pharmaceutical packaging market, accounting for 33% of market revenue, largely due to groundbreaking patient-centric innovations. One of the most notable advancements is the development of smart pill bottles equipped with highly sensitive weight sensors capable of detecting medication removal with an accuracy of up to 0.1 grams. These sensors enable precise monitoring of patient adherence by tracking when and how much medication is taken, facilitating better management of treatment regimens, especially for individuals with chronic conditions who require strict adherence to prescribed dosages.

In terms of products, plastic packaging holds a dominant position in the pharmaceutical packaging market, commanding a significant 36% market share. This leadership is largely driven by groundbreaking advancements in multilayer barrier films, which have dramatically improved the protective qualities required for sensitive pharmaceutical products. These films are engineered to achieve exceptionally low water vapor transmission rates, often falling below 0.0001 grams per square meter per day, effectively safeguarding medications from moisture-related degradation.

Segment Breakdown

By Drug Type

• Primary
• Secondary
• Tertiary

By Product

• Cardboard
  • Boxes
  • Cartons
  • Display Unit
• Paper
  • Label
  • Leaflet
  • Glass
• Ampoules
  • Bottles
  • Vials
  • Syringes
  • Cartridges
• Plastic
  • Closure
  • Bottles
  • Bags
  • Tubes
  • Injection Trays
  • Laminates with paper or foil
• Metal
  • Collapsible tubes
  • Rigid cans
  • Foils
  • Pressurized containers
• Rubber

By Application

• Oral Drugs
• Injectable
• Topical
• Ocular/ Ophthalmic
• Nasal
• Sublingual
• Pulmonary
• Transdermal
• IV Drugs
• Others

By Prescription Type

• Prescription
  • Branded drugs
  • Generic drugs
• OTC
  • Branded drugs
  • Generic drugs

By End-Use

• Pharma Manufacturing
• Contract Packaging
• Retail Pharmacy
• Institutional Pharmacy

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • The UK
  • Germany
  • France
  • Italy
  • Spain
  • Poland
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia & New Zealand
  • ASEAN
    • Malaysia
    • Singapore
    • Thailand
    • Indonesia
    • Philippines
    • Vietnam
    • Rest of ASEAN
  • Rest of Asia Pacific
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • South Africa
  • Rest of MEA
• South America
  • Argentina
  • Brazil
  • Rest of South America

Geographical Breakdown

North America's dominance in the pharmaceutical packaging market, commanding a substantial 41% share, is deeply rooted in its concentrated biotechnology clusters. These clusters serve as innovation hubs where packaging manufacturers and drug developers collaborate closely on research initiatives, driving the emergence of cutting-edge packaging solutions tailored to the unique demands of pharmaceutical products.

Central to this innovation are specialized testing laboratories established within these clusters, equipped with advanced environmental chambers capable of simulating extreme conditions. These chambers can replicate environments ranging from ultra-low temperatures of -80°C, akin to those in specialized freezers, to high heat and humidity levels of 40°C and 75% relative humidity. This capability allows for rapid and thorough validation of packaging performance, ensuring that pharmaceutical products remain stable and secure under various storage and transportation conditions.

Investment in advanced manufacturing technologies further strengthens North America's leadership in this market. In 2024 alone, the region saw investments totaling US$ 7.2 billion directed toward upgrading packaging facilities with state-of-the-art systems. Among these innovations are artificial intelligence-powered quality control systems that dramatically enhance defect detection efficiency, operating approximately 340 times faster than traditional manual inspections.

Leading Market Participants

• Amcor
• AptarGroup, Inc.
• Becton, Dickinson, and Company
• Berry Global, Inc.
• Catalent (US)
• CCL Industries, Inc.
• Comar, LLC
• Drug Plastics Group
• Gerresheimer AG
• International Paper
• Owens Illinois, Inc.
• Schott AG
• SGD Pharma
• Vetter Pharma International
• West Pharmaceutical Services, Inc.
• WestRock Company
• Other Prominent Players

Table of Content

Chapter 1. Research Framework

• 1.1 Research Objective
• 1.2 Product Overview
• 1.3 Market Segmentation

Chapter 2. Research Methodology

• 2.1 Qualitative Research
  • 2.1.1 Primary & Secondary Sources
• 2.2 Quantitative Research
  • 2.2.1 Primary & Secondary Sources
• 2.3 Breakdown of Primary Research Respondents, By Region
• 2.4 Assumption for the Study
• 2.5 Market Size Estimation
• 2.6. Data Triangulation

Chapter 3. Executive Summary: Global Pharmaceutical Packaging Market

Chapter 4. Global Pharmaceutical Packaging Market Overview

• 4.1. Industry Value Chain Analysis
  • 4.1.1. Raw Material Supplier
  • 4.1.2. Manufacturer
  • 4.1.3. Processing and Packaging
  • 4.1.4. Distributors
  • 4.1.5. End User
• 4.2. Industry Outlook
  • 4.2.1. Top pharmaceutical packaging companies and services
• 4.3. PESTLE Analysis
• 4.4. Porter's Five Forces Analysis
  • 4.4.1. Bargaining Power of Suppliers
  • 4.4.2. Bargaining Power of Buyers
  • 4.4.3. Threat of Substitutes
  • 4.4.4. Threat of New Entrants
  • 4.4.5. Degree of Competition
• 4.5. Market Dynamics and Trends
  • 4.5.1. Growth Drivers
  • 4.5.2. Restraints
  • 4.5.3. Challenges
  • 4.5.4. Key Trends
• 4.6. Covid-19 Impact Assessment on Market Growth Trend
• 4.7. Market Growth and Outlook
  • 4.7.1. Market Revenue Estimates and Forecast (US$ Bn), 2020 - 2033
  • 4.7.2. Pricing Analysis
• 4.8. Competition Dashboard
  • 4.8.1. Market Concentration Rate
  • 4.8.2. Company Market Share Analysis (Value %), 2024
  • 4.8.3. Competitor Mapping

Chapter 5. Pharmaceutical Packaging Market, By Packaging Type

• 5.1. Key Insights
• 5.2. Market Size and Forecast, 2020 - 2033 (US$ Bn)
  • 5.2.1. Primary
  • 5.2.2. Secondary
  • 5.2.3. Tertiary

Chapter 6. Pharmaceutical Packaging Market, By Product

• 6.1. Key Insights
• 6.2. Market Size and Forecast, 2020 - 2033 (US$ Bn)
  • 6.2.1. Cardboard

6.2.1.1. Boxes

6.2.1.2. Cartons

6.2.1.3. Display unit

• 6.2.2. Paper

6.2.2.1. Label

6.2.2.2. Leaflet

• 6.2.3. Glass

6.2.3.1. Ampoules

6.2.3.2. Bottles

6.2.3.3. Vials

6.2.3.4. Syringes

6.2.3.5. Cartridges

• 6.2.4. Plastic

6.2.4.1. Closure

6.2.4.2. Bottles

6.2.4.3. Bags

6.2.4.4. Tubes

6.2.4.5. Injection Trays

6.2.4.6. Laminates with paper or foil

• 6.2.5. Metal

6.2.5.1. Collapsible tubes

6.2.5.2. Rigid cans

6.2.5.3. Foils

6.2.5.4. Pressurized containers

• 6.2.6. Rubber

Chapter 7. Pharmaceutical Packaging Market, By Drug Type

• 7.1. Key Insights
• 7.2. Market Size and Forecast, 2020 - 2033 (US$ Bn)
  • 7.2.1. Oral Drugs
  • 7.2.2. Injectables
  • 7.2.3. Topical
  • 7.2.4. Ocular/ Ophthalmic
  • 7.2.5. Nasal
  • 7.2.6. Sublingual
  • 7.2.7. Pulmonary
  • 7.2.8. Transdermal
  • 7.2.9. IV Drugs
  • 7.2.10. Others

Chapter 8. Pharmaceutical Packaging Market, By Prescription Type

• 8.1. Key Insights
• 8.2. Market Size and Forecast, 2020 - 2033 (US$ Bn)
  • 8.2.1. Prescription
    • 8.2.1.1. Branded Drugs
    • 8.2.1.2. Generic drugs
  • 8.2.2. OTC
    • 8.2.2.1. Branded Drugs
    • 8.2.2.2. Generic drugs

Chapter 9. Pharmaceutical Packaging Market, By End Use

• 9.1. Key Insights
• 9.2. Market Size and Forecast, 2020 - 2033 (US$ Bn)
  • 9.2.1. Pharma Manufacturing
  • 9.2.2. Contract Packaging
  • 9.2.3. Retail Pharmacy
  • 9.2.4. Institutional Pharmacy

Chapter 10. Pharmaceutical Packaging Market, By Region/ Country

• 10.1. Key Insights
• 10.2. Market Size and Forecast, 2020 - 2033 (US$ Bn)
  • 10.2.1. North America
    • 10.2.1.1. The U.S.
    • 10.2.1.2. Canada
    • 10.2.1.3. Mexico
  • 10.2.2. Europe
    • 10.2.2.1. The UK
    • 10.2.2.2 Germany
    • 10.2.2.3 France
    • 10.2.2.4. Spain
    • 10.2.2.5. Italy
    • 10.2.2.6. Russia
    • 10.2.2.7. Poland
    • 10.2.2.8. Rest of Europe
  • 10.2.3. Asia Pacific
    • 10.2.3.1. China
    • 10.2.3.2. India
    • 10.2.3.3. Japan
    • 10.2.3.4. Australia & New Zealand
    • 10.2.3.5. ASEAN
    • 10.2.3.6. Rest of Asia Pacific
  • 10.2.4. Middle East & Africa (MEA)
    • 10.2.4.1. UAE
    • 10.2.4.2. Saudi Arabia
    • 10.2.4.3. South Africa
    • 10.2.4.4. Rest of MEA
  • 10.2.5. South America
    • 10.2.5.1. Brazil
    • 10.2.5.2. Argentina
    • 10.2.5.3. Rest of South America

Chapter 11. North America Pharmaceutical Packaging Market Analysis

• 11.1. Key Insights
• 11.2. Market Size and Forecast, 2020 - 2033 (US$ Bn)
  • 11.2.1. By Packaging Type
  • 11.2.2. By Product Type
  • 11.2.3. By Application
  • 11.2.4. By End Use
  • 11.2.5. By Prescription Type
  • 11.2.6. By Country

Chapter 12. The U.S. Pharmaceutical Packaging Market Analysis

• 12.1. Key Insights
• 12.2. Market Size and Forecast, 2020 - 2033 (US$ Bn)
  • 12.2.1. By Packaging Type
  • 12.2.2. By Product Type
  • 12.2.3. By Application
  • 12.2.4. By End Use
  • 12.2.5. By Prescription Type

Chapter 13. Canada Pharmaceutical Packaging Market Analysis

• 13.1. Key Insights
• 13.2. Market Size and Forecast, 2020 - 2033 (US$ Bn)
  • 13.2.1. By Packaging Type
  • 13.2.2. By Product Type
  • 13.2.3. By Application
  • 13.2.4. By End Use
  • 13.2.5. By Prescription Type

Chapter 14. Europe Pharmaceutical Packaging Market Analysis

• 14.1. Key Insights
• 14.2. Market Size and Forecast, 2020 - 2033 (US$ Bn)
  • 14.2.1. By Packaging Type
  • 14.2.2. By Product Type
  • 14.2.3. By Application
  • 14.2.4. By End Use
  • 14.2.5. By Prescription Type
  • 14.2.5. By Country

Chapter 15. Asia Pacific Pharmaceutical Packaging Market Analysis

• 15.1. Key Insights
• 15.2. Market Size and Forecast, 2020 - 2033 (US$ Bn)
  • 15.2.1. By Packaging Type
  • 15.2.2. By Product Type
  • 15.2.3. By Application
  • 15.2.4. By End Use
  • 15.2.5. By Prescription Type
  • 15.2.6. By Country

Chapter 16. Japan Pharmaceutical Packaging Market Analysis

• 16.1. Key Insights
• 16.2. Market Size and Forecast, 2020 - 2033 (US$ Bn)
  • 16.2.1. By Packaging Type
  • 16.2.2. By Product Type
  • 16.2.3. By Application
  • 16.2.4. By End Use
  • 16.2.4. By Prescription Type

Chapter 17. ASEAN Pharmaceutical Packaging Market Analysis

• 17.1. Key Insights
• 17.2. Market Size and Forecast, 2020 - 2033 (US$ Bn)
  • 17.2.1. By Packaging Type
  • 17.2.2. By Product Type
  • 17.2.3. By Application
  • 17.2.4. By End Use
  • 17.2.5. By Prescription Type
  • 17.2.6. By Country

Chapter 18. Middle East & Africa Pharmaceutical Packaging Market Analysis

• 18.1. Key Insights
• 18.2. Market Size and Forecast, 2020 - 2033 (US$ Bn)
  • 18.2.1. By Packaging Type
  • 18.2.2. By Product Type
  • 18.2.3. By Application
  • 18.2.4. By End Use
  • 18.2.5. By Prescription Type
  • 18.2.6. By Country

Chapter 19. South America Pharmaceutical Packaging Market Analysis

• 19.1. Key Insights
• 19.2. Market Size and Forecast, 2020 - 2033 (US$ Bn)
  • 19.2.1. By Packaging Type
  • 19.2.2. By Product Type
  • 19.2.3. By Application
  • 19.2.4. By End Use
  • 19.2.5. By Prescription Type
  • 19.2.6. By Country

Chapter 20. Company Profile (Company Overview, Financial Matrix, Sales Composition Ration, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Business Strategy Outlook)

• 20.1. Amcor
• 20.2. AptarGroup, Inc.
• 20.3. Becton, Dickinson, and Company
• 20.4. Berry Global, Inc.
• 20.5. Catalent (US)
• 20.6. CCL Industries, Inc.
• 20.7. Comar, LLC
• 20.8. Drug Plastics Group
• 20.9. Gerresheimer AG
• 20.10. International Paper
• 20.11. Owens Illinois, Inc.
• 20.12. Schott AG
• 20.13. SGD Pharma
• 20.14. Vetter Pharma International
• 20.15. West Pharmaceutical Services, Inc.
• 20.16. WestRock Company
• 20.17. Other Prominent Players